// App-Quantinova.ai

4132 : Multiple drug resistance-associated protein 4 (MRP4): Role in triple negative breast cancer

Researchers

Presenter

  • Tyler Kochel

Principal Investigators

  • Xinrong Ma

  • Namita Kundu

  • Jocelyn Reader

  • Olga Goloubeva

  • Amy M. Fulton

Medical Centers

  • University of Maryland Greenebaum Cancer Center, Baltimore, MD

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

  • Epithelial tumors

  • Basal-type tumors

  • Breast cancer

  • Solid malignancies

Biomarkers

  • 15-Hydroxyprostaglandin Dehydrogenase

  • ATP-binding cassette sub-family C member 4

  • Prostaglandin E2

  • Cyclooxygenase-2

Drug/Treatment

  • Dinoprostone

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved